Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine, Pomalidomide, and Dexamethasone in RRMM
NCT04762745Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04762745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762745.